for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Sanofi - new suitor for Actelion?

Posted

After Johnson & Johnson ended its bid, France's Sanofi is reported to be the next suitor in waiting for a tie-up with Europe's largest biotechnology drug maker, Actelion. As Ciara Lee reports, a deal could value Actelion at as much as $30 billion.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up